Warby Parker Inc.
General ticker "WRBY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $2.7B (TTM average)
Warby Parker Inc. follows the US Stock Market performance with the rate: 52.6%.
Estimated limits based on current volatility of 4.3%: low 25.87$, high 28.20$
Factors to consider:
- Total employees count: 3780 (+8.3%) as of 2024
- Top business risk factors: Growth challenges, Reputation and brand risks, E commerce risks, Corporate culture maintenance, Market competition
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [18.79$, 29.38$]
- 2026-12-31 to 2027-12-31 estimated range: [20.25$, 31.45$]
Financial Metrics affecting the WRBY estimates:
- Positive: with PPE of 75.9 at the end of fiscal year the price was neutral
- Positive: -4.75 < Operating profit margin, % of -0.61
- Positive: 42.68 < Shareholder equity ratio, % of 51.01 <= 64.29
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 1.99
- Negative: Industry inventory ratio change (median), % of 0.37 > 0.31
- Positive: -4.43 < Investing cash flow per share per price, % of -2.19
Short-term WRBY quotes
Long-term WRBY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $669.76MM | $771.32MM | $871.90MM |
| Operating Expenses | $741.76MM | $801.43MM | $877.24MM |
| Operating Income | $-72.00MM | $-30.11MM | $-5.34MM |
| Non-Operating Income | $9.23MM | $10.60MM | $8.38MM |
| Income(Loss) | $-62.76MM | $-19.52MM | $3.04MM |
| Taxes | $0.43MM | $0.88MM | $1.40MM |
| Profit(Loss)* | $-63.20MM | $-20.39MM | $1.64MM |
| Stockholders Equity | $301.79MM | $340.07MM | $367.73MM |
| Inventory | $62.23MM | $52.34MM | $44.51MM |
| Assets | $580.31MM | $676.49MM | $720.92MM |
| Operating Cash Flow | $60.99MM | $98.74MM | $110.78MM |
| Capital expenditure | $53.67MM | $64.03MM | $67.05MM |
| Investing Cash Flow | $-54.67MM | $-66.03MM | $-67.05MM |
| Financing Cash Flow | $2.87MM | $4.96MM | $-12.00MM |
| Earnings Per Share** | $-0.54 | $-0.17 | $0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.